satavaptan has been researched along with Diabetes Mellitus in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andersen, PK; Jepsen, P; Vilstrup, H; Watson, H | 1 |
Bankir, L; Bardoux, P; Bouby, N; Bruneval, P; Heudes, D | 1 |
1 trial(s) available for satavaptan and Diabetes Mellitus
Article | Year |
---|---|
Diabetes as a risk factor for hepatic encephalopathy in cirrhosis patients.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Diabetes Mellitus; Dose-Response Relationship, Drug; Female; Follow-Up Studies; France; Hepatic Encephalopathy; Humans; Incidence; Liver Cirrhosis; Male; Middle Aged; Morpholines; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Spiro Compounds; Survival Rate; Time Factors | 2015 |
1 other study(ies) available for satavaptan and Diabetes Mellitus
Article | Year |
---|---|
Diabetes-induced albuminuria: role of antidiuretic hormone as revealed by chronic V2 receptor antagonism in rats.
Topics: Albuminuria; Animals; Antidiuretic Hormone Receptor Antagonists; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Kidney; Male; Morpholines; Rats; Rats, Wistar; Receptors, Vasopressin; Spiro Compounds; Streptozocin; Vasopressins | 2003 |